end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableTradeCurrent,AccountsReceivableNetCurrent,AccruedEmployeeBenefitsCurrent,AccruedIncomeTaxesCurrent,AccruedIncomeTaxesNoncurrent,AccruedLiabilitiesCurrent,AccruedRoyaltiesCurrent,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,AccumulatedOtherComprehensiveIncomeLossNetOfTax,AdditionalPaidInCapital,AdjustmentsToAdditionalPaidInCapitalIncomeTaxDeficiencyFromShareBasedCompensation,AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition,AdvertisingExpense,AllocatedShareBasedCompensationExpense,AllowanceForDoubtfulAccountsReceivableCurrent,AmortizationOfFinancingCosts,AmortizationOfIntangibleAssets,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,Assets,AssetsCurrent,AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent,BusinessAcquisitionPercentageOfVotingInterestsAcquired,BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1,CapitalizedContractCostNet,CapitalLeaseObligationsCurrent,CapitalLeaseObligationsIncurred,CapitalLeaseObligationsNoncurrent,CapitalLeasesFutureMinimumPaymentsDue,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect,CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations,CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations,CommonStockOtherSharesOutstanding,CommonStockOtherValueOutstanding,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,ComprehensiveIncomeNetOfTax,ConstructionInProgressExpendituresIncurredButNotYetPaid,ConstructionInProgressGross,ContractWithCustomerAssetNet,ContractWithCustomerLiabilityCurrent,ContractWithCustomerLiabilityNoncurrent,ContractWithCustomerRefundLiabilityCurrent,CostOfGoodsAndServicesSold,CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption,CurrentFederalTaxExpenseBenefit,CurrentForeignTaxExpenseBenefit,CurrentIncomeTaxExpenseBenefit,CurrentStateAndLocalTaxExpenseBenefit,DebtInstrumentCarryingAmount,DebtInstrumentFaceAmount,DeferredFederalIncomeTaxExpenseBenefit,DeferredFinanceCostsNet,DeferredForeignIncomeTaxExpenseBenefit,DeferredIncomeCurrent,DeferredIncomeTaxAssetsNet,DeferredIncomeTaxExpenseBenefit,DeferredIncomeTaxesAndTaxCredits,DeferredIncomeTaxLiabilitiesNet,DeferredStateAndLocalIncomeTaxExpenseBenefit,DeferredTaxAssetsGoodwillAndIntangibleAssets,DeferredTaxAssetsInventory,DeferredTaxAssetsInvestmentInSubsidiaries,DeferredTaxAssetsOperatingLossCarryforwards,DeferredTaxAssetsOther,DeferredTaxAssetsTaxCreditCarryforwards,DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost,DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities,DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts,DeferredTaxAssetsValuationAllowance,DeferredTaxLiabilities,DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets,DeferredTaxLiabilitiesLeasingArrangements,DeferredTaxLiabilitiesNoncurrent,DeferredTaxLiabilitiesOther,DeferredTaxLiabilitiesPrepaidExpenses,DeferredTaxLiabilitiesPropertyPlantAndEquipment,DefinedContributionPlanCostRecognized,DefinedContributionPlanEmployerMatchingContributionPercent,Depreciation,DepreciationDepletionAndAmortization,DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax,DiscontinuedOperationTaxEffectOfDiscontinuedOperation,DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent,DisposalGroupIncludingDiscontinuedOperationConsideration,EarningsPerShareBasic,EarningsPerShareBasicAndDiluted,EarningsPerShareDiluted,EffectiveIncomeTaxRateContinuingOperations,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance,EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate,EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential,EffectiveIncomeTaxRateReconciliationNondeductibleExpense,EffectiveIncomeTaxRateReconciliationOtherAdjustments,EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes,EffectiveIncomeTaxRateReconciliationTaxCredits,EffectiveIncomeTaxRateReconciliationTaxSettlements,EffectOfExchangeRateOnCashAndCashEquivalents,EffectOnFutureEarningsAmount,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions,EmployeeStockOwnershipPlanESOPCompensationExpense,FinanceLeaseInterestPaymentOnLiability,FinanceLeaseLiability,FinanceLeaseLiabilityCurrent,FinanceLeaseLiabilityNoncurrent,FinanceLeaseLiabilityPaymentsDue,FinanceLeaseLiabilityUndiscountedExcessAmount,FinanceLeasePrincipalPayments,FinanceLeaseRightOfUseAsset,FinanceLeaseWeightedAverageDiscountRatePercent,FiniteLivedIntangibleAssetsAccumulatedAmortization,FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive,FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths,FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear,FiniteLivedIntangibleAssetsAmortizationExpenseYearFive,FiniteLivedIntangibleAssetsAmortizationExpenseYearFour,FiniteLivedIntangibleAssetsAmortizationExpenseYearThree,FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo,FiniteLivedIntangibleAssetsNet,GainLossOnDispositionOfAssets,GainLossOnDispositionOfIntangibleAssets,GainLossOnSaleOfBusiness,Goodwill,GoodwillAndIntangibleAssetImpairment,GoodwillImpairedAccumulatedImpairmentLoss,GoodwillImpairmentLoss,GrossProfit,ImpairmentOfIntangibleAssetsExcludingGoodwill,ImpairmentOfIntangibleAssetsFinitelived,ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill,IncomeLossFromContinuingOperations,IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign,IncomeLossFromContinuingOperationsPerBasicAndDilutedShare,IncomeLossFromContinuingOperationsPerBasicShare,IncomeLossFromContinuingOperationsPerDilutedShare,IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity,IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare,IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare,IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare,IncomeTaxExaminationIncreaseDecreaseInLiabilityFromPriorYear,IncomeTaxExaminationInterestExpense,IncomeTaxExaminationPenaltiesAndInterestExpense,IncomeTaxExpenseBenefit,IncomeTaxesPaidNet,IncreaseDecreaseInAccountsPayableTrade,IncreaseDecreaseInAccountsReceivable,IncreaseDecreaseInInventories,IncreaseDecreaseInOtherNoncurrentAssets,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,IndefinitelivedIntangibleAssetsAcquired,IntangibleAssetsGrossExcludingGoodwill,IntangibleAssetsNetExcludingGoodwill,InterestExpense,InterestPaidNet,InventoryFinishedGoodsNetOfReserves,InventoryNet,InventoryRawMaterialsAndSuppliesNetOfReserves,InventoryWorkInProcessNetOfReserves,LeaseCost,LesseeOperatingLeaseLiabilityPaymentsDue,LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths,LesseeOperatingLeaseLiabilityPaymentsDueYearFive,LesseeOperatingLeaseLiabilityPaymentsDueYearFour,LesseeOperatingLeaseLiabilityPaymentsDueYearThree,LesseeOperatingLeaseLiabilityPaymentsDueYearTwo,LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear,LesseeOperatingLeaseLiabilityUndiscountedExcessAmount,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent,LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent,LimitedPartnersCapitalAccount,LineOfCredit,LineOfCreditFacilityMaximumBorrowingCapacity,LitigationSettlementAmountAwardedToOtherParty,LongTermDebt,LongTermDebtCurrent,LongTermDebtNoncurrent,LongTermPurchaseCommitmentAmount,LossContingencyLossInPeriod,LossContingencyNumberOfDefendants,LossContingencyNumberOfPlaintiffs,LossContingencyPendingClaimsNumber,LossContingencyReceivableCurrent,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInFinancingActivitiesContinuingOperations,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInInvestingActivitiesContinuingOperations,NetCashProvidedByUsedInOperatingActivities,NetCashProvidedByUsedInOperatingActivitiesContinuingOperations,NetIncomeLoss,NetIncomeLossNetOfTaxPerOutstandingLimitedPartnershipUnitDiluted,NetIncomeLossPerOutstandingLimitedPartnershipUnitBasicNetOfTax,NonoperatingIncomeExpense,NumberOfOperatingSegments,NumberOfReportableSegments,NumberOfReportingUnits,OperatingExpenses,OperatingIncomeLoss,OperatingLeaseLiability,OperatingLeaseLiabilityCurrent,OperatingLeaseLiabilityNoncurrent,OperatingLeasePayments,OperatingLeaseRightOfUseAsset,OperatingLeasesFutureMinimumPaymentsDue,OperatingLeasesFutureMinimumPaymentsDueCurrent,OperatingLeasesFutureMinimumPaymentsDueInFiveYears,OperatingLeasesFutureMinimumPaymentsDueInFourYears,OperatingLeasesFutureMinimumPaymentsDueInThreeYears,OperatingLeasesFutureMinimumPaymentsDueInTwoYears,OperatingLeasesFutureMinimumPaymentsDueThereafter,OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear,OperatingLeaseWeightedAverageDiscountRatePercent,OtherAssetsNoncurrent,OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax,OtherLiabilitiesNoncurrent,OtherNonoperatingIncomeExpense,PaidInKindInterest,PartnersCapital,PartnersCapitalAccountContributions,PartnersCapitalAccountDistributions,PaymentForContingentConsiderationLiabilityFinancingActivities,PaymentForContingentConsiderationLiabilityOperatingActivities,PaymentsForRepurchaseOfCommonStock,PaymentsOfCapitalDistribution,PaymentsOfDistributionsToAffiliates,PaymentsOfLoanCosts,PaymentsRelatedToTaxWithholdingForShareBasedCompensation,PaymentsToAcquireIntangibleAssets,PaymentsToAcquirePropertyPlantAndEquipment,PreferredStockParOrStatedValuePerShare,PreferredStockSharesAuthorized,PreferredStockSharesIssued,PreferredStockSharesOutstanding,PreferredStockValue,PrepaidExpenseAndOtherAssetsCurrent,ProceedsFromDivestitureOfBusinessesNetOfCashDivested,ProceedsFromIssuanceOfCommonStock,ProceedsFromIssuanceOfDebt,ProceedsFromPartnershipContribution,ProceedsFromSaleOfIntangibleAssets,ProceedsFromSaleOfProductiveAssets,ProceedsFromSaleOfPropertyPlantAndEquipment,ProfitLoss,PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization,PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization,PropertyPlantAndEquipmentDisposals,PropertyPlantAndEquipmentGross,PropertyPlantAndEquipmentNet,ProvisionForDoubtfulAccounts,PurchaseObligation,PurchaseObligationDueInFourthAndFifthYear,PurchaseObligationDueInNextTwelveMonths,PurchaseObligationDueInSecondAndThirdYear,RelatedPartyTransactionAmountsOfTransaction,RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty,RepaymentsOfDebt,RepaymentsOfLongTermCapitalLeaseObligations,RepaymentsOfLongTermDebt,ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff,ResearchAndDevelopmentExpense,ResearchAndDevelopmentInProcess,RestructuringAndRelatedCostIncurredCost,RestructuringAndRelatedCostNumberOfPositionsEliminated,RetainedEarningsAccumulatedDeficit,RevenueFromContractWithCustomerExcludingAssessedTax,RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability,RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability,SaleOfStockConsiderationReceivedOnTransaction,SaleOfStockPricePerShare,SellingGeneralAndAdministrativeExpense,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted,ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1,SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent,StockholdersEquity,StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan,StockIssuedDuringPeriodSharesNewIssues,StockIssuedDuringPeriodValueNewIssues,StockIssuedDuringPeriodValueShareBasedCompensation,StockRepurchasedAndRetiredDuringPeriodShares,StockRepurchasedAndRetiredDuringPeriodValue,StockRepurchasedDuringPeriodShares,StockRepurchasedDuringPeriodValue,StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased,TaxAdjustmentsSettlementsAndUnusualProvisions,TaxCreditCarryforwardAmount,UnrecognizedTaxBenefits,UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions,UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued,UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense,UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions,UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate,ValuationAllowanceDeferredTaxAssetChangeInAmount,ValuationAllowancesAndReservesBalance,ValuationAllowancesAndReservesChargedToCostAndExpense,ValuationAllowancesAndReservesDeductions,WeightedAverageLimitedPartnershipUnitsOutstanding,WeightedAverageLimitedPartnershipUnitsOutstandingDiluted,WeightedAverageNumberOfDilutedSharesOutstanding,WeightedAverageNumberOfShareOutstandingBasicAndDiluted,WeightedAverageNumberOfSharesOutstandingBasic,WriteOffOfDeferredDebtIssuanceCost
2018-09-30,2018-11-08,10-Q,Osmotica Pharmaceuticals plc,RVLP,CIK0001739426,USD,27860913.0,72718271.0,6659670.0,,2066955.0,81576774.0,7661494.0,,-1871673.0,,,,,0.0,513413.0,,19302133.0,70400.0,894917120.0,149316694.0,,,,0.0,110769.0,,148826.0,259596.0,32202522.0,,,,,,,,,,,-3754439.0,,,0.0,,0.0,44630959.0,33356208.0,,,,,,,,,5775696.0,,,,,,36299971.0,,,,,,,,,,,,,,,35173098.0,,,,,,,,,,,,,-0.08,,,,,,,,,,,,,,,,,,,,,,,,,,140470085.0,162847691.0,,18974028.0,43919941.0,66160668.0,68324749.0,69711697.0,429938774.0,,,,187172816.0,,,,32988637.0,6173000.0,,,,,-7478257.0,,,,,,,,,,,,-3872001.0,,,,,,,,667881859.0,521238774.0,5311330.0,,14338521.0,25593897.0,7077597.0,4177779.0,,,,,,,,,,464138876.0,894917120.0,115614205.0,,,417374758.0,,,,316074668.0,6065749.0,310008919.0,,,,,,,,,,,,,-3606256.0,-4.99,0.09,434065.0,,,,35589629.0,-2600992.0,,,,,,5425031.0,,870344.0,1099551.0,1364334.0,1327606.0,490514.0,272682.0,,799658.0,-148183.0,,434065.0,,430778239.0,,,,,,,,,,,,,,,,,23889636.0,,,,,,,,-3606256.0,,,,,31301546.0,,16000000.0,4000000.0,4000000.0,8000000.0,51271.0,,,,,,11964949.0,,,,,66344845.0,,,,,17451680.0,,,,,,,,,,,,,,,,,,,,,-1500000.0,,,,,,,,,,,,1000515.0,42862063.0,,42862063.0,,
2018-12-31,2019-03-28,10-K,Osmotica Pharmaceuticals plc,RVLP,CIK0001739426,USD,24871000.0,56424000.0,8673000.0,393552.0,2541000.0,87237000.0,3598000.0,10236000.0,-1846000.0,487288000.0,,717000.0,6200000.0,2000000.0,,1652000.0,77096000.0,,795624000.0,172364000.0,,,,0.0,119000.0,287542.0,138000.0,257293.0,70834000.0,37028000.0,,,0.0,,0.01,400000000.0,52518924.0,52518924.0,525000.0,-110894000.0,1502000.0,3418000.0,0.0,101354.0,0.0,48464000.0,140082000.0,,2903000.0,2089000.0,6530000.0,1538000.0,273134135.0,,-7828000.0,4557025.0,-3680000.0,101000.0,,-15513000.0,-15513000.0,28294000.0,-4005000.0,,491000.0,9537000.0,2820000.0,1229000.0,4617000.0,439000.0,12640000.0,44000.0,298000.0,28294000.0,55983000.0,,26237841.0,,828000.0,3002000.0,1100000.0,,4500000.0,81573000.0,,,,,,-2.42,,0.0757,0.21,0.0,0.0,-0.1008,-0.0846,-0.0124,0.0168,0.0454,,-938000.0,,,5062986.0,,,,,,,,,300000.0,,159589000.0,122915748.0,68899197.0,,38906920.0,43107441.0,65348168.0,67512249.0,406689723.0,-93000.0,,,55847000.0,,,86318000.0,123619000.0,17903000.0,10300000.0,,,-52759000.0,-118664000.0,-65905000.0,,,,,,,,,,,-8983000.0,2638000.0,-11326000.0,17041000.0,7436000.0,,-4549000.0,,667882000.0,83700000.0,20790000.0,19619000.0,15577000.0,24383000.0,7667000.0,1139000.0,,,,,,,,,,411777000.0,795624000.0,114001000.0,,,,,,,268577000.0,1774000.0,266803000.0,,,,,,,3604000.0,,-4134000.0,,37558000.0,,-109681000.0,-2.42,-2.42,664000.0,1.0,1.0,1.0,222157000.0,-98538000.0,,,,,,5803272.0,1997564.0,490514.0,859184.0,1084566.0,1371444.0,,,,752000.0,-1257000.0,,664391.0,,,,,,,,,2000.0,,,,4144000.0,0.01,40000000.0,0.0,0.0,,20723000.0,,58084000.0,,,,,10000.0,-211801000.0,,,,38081000.0,31263000.0,-1771000.0,4000000.0,,4000000.0,,,246092.0,56140000.0,112000.0,,,43693000.0,,,,-102120000.0,263701000.0,,,,,74243000.0,1965000.0,,,,,,,,3698.0,,383847000.0,,,58084000.0,,,,,,,,4600000.0,2218000.0,,300000.0,100000.0,571000.0,0.0,1800000.0,91797063.0,,626777861.0,45276278.0,,,45276278.0,,876000.0
2019-03-31,2019-05-09,10-Q,Osmotica Pharmaceuticals plc,RVLP,CIK0001739426,USD,20590796.0,56886524.0,4145962.0,496029.0,2541000.0,72478973.0,1820224.0,,-1846183.0,491118654.0,,1169000.0,,1200000.0,,323000.0,16900000.0,,775877000.0,163962013.0,,,,0.0,,,,,63062000.0,-7772000.0,,,0.0,,0.01,400000000.0,52518924.0,52518924.0,525189.0,-6687000.0,,,0.0,,0.0,45708355.0,29203000.0,,,,,,,,,4280382.0,,,,-1400734.0,-1060000.0,27234000.0,,,,,,,,,,,,,,,24837107.0,,,,,,,17993000.0,,,,,,-0.13,,,0.24,,,,,,,,,,,,14054288.0,,1146.0,244262.0,124590.0,119672.0,248831.0,4569.0,31000.0,254182.0,0.0173,176457063.0,136686904.0,,50604405.0,49123534.0,51294844.0,58183460.0,63628441.0,409521588.0,-53000.0,,,100854816.0,,,,27923000.0,0.0,,,,,-7441000.0,,,,,,,,,,,,-754000.0,215000.0,-4279000.0,378000.0,3432000.0,,-4691000.0,,649978651.0,473521588.0,4501000.0,4069000.0,15791471.0,27814847.0,11283875.0,739501.0,631911.0,7179103.0,,490515.0,879504.0,1801411.0,2296677.0,1710996.0,595521.0,397547000.0,775877000.0,96492270.0,,,,0.0,50000000.0,,267874624.0,795068.0,267079556.0,,,,,,,-1010000.0,,-635000.0,,-6127000.0,,-6687000.0,,-0.13,557000.0,1.0,1.0,,31420000.0,-3497000.0,6583582.0,2006814.0,4576768.0,599188.0,6364515.0,,,,,,,,,0.0515,705266.0,,,556947.0,,,,,,,,,,,,,635000.0,0.01,40000000.0,0.0,0.0,,15929000.0,,,,,,,,-6687000.0,,,,,30738375.0,-84000.0,4000000.0,,4000000.0,,100000.0,,,,,,9764000.0,,,,-108559972.0,57126000.0,18284.0,815619.0,,,21656000.0,1169000.0,1374335.0,,,0.0,1374335.0,1374335.0,,,,378329000.0,,,,1168863.0,,,,,,,,,,,,,,,,,,,,,52518924.0,,
2019-06-30,2019-08-08,10-Q,Osmotica Pharmaceuticals plc,RVLP,CIK0001739426,USD,18916544.0,68142413.0,6551636.0,134405.0,2541000.0,75524908.0,2450149.0,,-1846183.0,492445699.0,,1327000.0,,1300000.0,,,16900000.0,,643781000.0,173974797.0,,,,0.0,,,,,63737000.0,,,,0.0,,0.01,400000000.0,52518924.0,52518924.0,525189.0,-124869000.0,,,0.0,,0.0,47127234.0,32644000.0,,,,,,,,,3994309.0,,,,,,16834000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,-2.38,,,,,,,,,,,,,,,12952690.0,,,231868.0,130505.0,101363.0,236084.0,4216.0,,248453.0,0.0179,193325197.0,70913195.0,,26901570.0,35834234.0,38005544.0,44894160.0,50339141.0,266887844.0,,,,100854816.0,,,,24888000.0,125766000.0,,,,,-136316000.0,,,,,,,,,,,,-11447000.0,,,,,,,,649978651.0,330887844.0,4552000.0,,15523131.0,27875268.0,10993177.0,1358960.0,676771.0,7170402.0,,490515.0,907013.0,2049045.0,2485755.0,1238074.0,581678.0,388994000.0,643781000.0,97903859.0,,,,0.0,50000000.0,,268357088.0,991459.0,267365629.0,,,,,,,,,,,,,-124869000.0,,-2.38,-15000.0,,,,156637000.0,-131749000.0,6588724.0,2206038.0,4382686.0,,6375357.0,,,,,,,,,0.0505,658069.0,,,,,,,,,,,,,,,,,0.01,40000000.0,0.0,0.0,,14166000.0,,,,,,,,-124869000.0,,,,,31084436.0,,,,,,44086.0,,,,,,5360000.0,,,,-233213959.0,57532000.0,,553860.0,,,25511000.0,,,,,,69185.0,1438016.0,,,,254787000.0,,,,1327045.0,,,,,,,,,,,,,,,,,,,,,52518924.0,,
2019-09-30,2019-11-14,10-Q,Osmotica Pharmaceuticals plc,RVLP,CIK0001739426,USD,9905196.0,33861954.0,6537860.0,,2478596.0,66075638.0,2281774.0,,-2229367.0,489784434.0,,1335000.0,,1300000.0,,,13500000.0,,494173194.0,167302164.0,,,,0.0,,,,,98014000.0,,,,0.0,,0.01,400000000.0,52163353.0,52163353.0,521634.0,-113087771.0,,,0.0,,0.0,38176442.0,27312000.0,,,,,,,,,3698804.0,,,198372.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-2.15,,,,,,,,,,,,,,27102.0,11404977.0,4517.0,,198659.0,129878.0,68782.0,201885.0,3226.0,,215198.0,0.018,206775981.0,50030196.0,,5469785.0,14485234.0,15365544.0,19842160.0,20131141.0,125324060.0,,,,100854816.0,,,0.0,38149000.0,128113000.0,,0.0,,,-127327000.0,,,,,,,,,,,,-14623000.0,,,,,,,,649978651.0,189324060.0,4504000.0,,17198526.0,27239963.0,7837146.0,2204291.0,668834.0,6249708.0,,490514.0,928507.0,1923401.0,2329009.0,578277.0,490448.0,352476404.0,494173194.0,78590824.0,,,,0.0,50000000.0,,268059054.0,397920.0,267661134.0,,,,,,,,,,,,,-112704000.0,,,177000.0,,,,161149000.0,-123000000.0,5759260.0,2082192.0,3677068.0,,5558236.0,,,,,,,,,0.052,610340.0,-383000.0,,,,,,,,,,,,,,,,0.01,40000000.0,0.0,0.0,,8185889.0,,,,,,,,-112705000.0,,,350022.0,,30325206.0,,,,,,35489.0,,,,,,8285000.0,,,,-346379911.0,65461000.0,0.0,62268.0,,,24751000.0,,,,,,27500.0,1440081.0,,,,141696000.0,0.0,,,1335430.0,,1338000.0,355571.0,1338430.0,5251892.0,,,,,,,,,,,,,,,,52476540.0,,
2019-12-31,2020-03-19,10-K,Osmotica Pharmaceuticals plc,RVLP,CIK0001739426,USD,1487000.0,794000.0,7632000.0,,,17637000.0,3649000.0,14292000.0,-2229000.0,489440000.0,,4932000.0,6900000.0,4000000.0,,1337000.0,1970000.0,,463255000.0,172630000.0,66804000.0,,,0.0,,,,,95865000.0,24856000.0,,,0.0,,0.01,400000000.0,51845742.0,51845742.0,518000.0,-271284000.0,1900000.0,1000.0,0.0,,0.0,55000.0,3122000.0,,-16970000.0,-2849000.0,-20411000.0,-592000.0,271360000.0,,-5785000.0,3400000.0,689000.0,,,-5815000.0,-26794000.0,1500000.0,-719000.0,,243000.0,8696000.0,2627000.0,1685000.0,3249000.0,1399000.0,9535000.0,31000.0,21216000.0,1500000.0,3814000.0,3814000.0,,1115000.0,689000.0,3252000.0,1300000.0,0.03,1300000.0,57015000.0,-165245000.0,-895000.0,164250000.0,,,-5.17,,0.1971,0.21,-0.0139,0.0,-0.0443,0.0021,0.0048,0.0228,0.0132,0.0,175000.0,,,2200000.0,31619.0,1000.0,200000.0,26000.0,20000.0,200000.0,,130000.0,47000.0,0.0157,1970000.0,20203000.0,17450000.0,,10682000.0,11805000.0,12685000.0,17161000.0,89986000.0,-173000.0,,,55847000.0,,86300000.0,0.0,-1920000.0,283747000.0,283700000.0,,-106551000.0,-85954000.0,-132777000.0,-46823000.0,-2.43,,,-164350000.0,-2.75,,,,,,-26226000.0,1290000.0,-16375000.0,-12674000.0,-3078000.0,,-9177000.0,,83700000.0,64000000.0,6014000.0,15181000.0,119000.0,395000.0,276000.0,778000.0,2057000.0,5596000.0,2285000.0,,490000.0,929000.0,1892000.0,,418000.0,348547000.0,463255000.0,75937000.0,54984000.0,847000.0,,,,,267950000.0,,267950000.0,,,,,,,-4691000.0,,-4020000.0,,33567000.0,,-270901000.0,,,995000.0,1.0,1.0,1.0,125838000.0,-127758000.0,5178000.0,1803000.0,2293000.0,2030000.0,3916000.0,,,,,,,,,0.0501,563000.0,-383000.0,,,,,,,,,2787000.0,,,,,0.0,3963000.0,0.01,40000000.0,0.0,0.0,,8772000.0,,,,,,,17000.0,-270901000.0,1787000.0,2049000.0,400000.0,43116000.0,30238000.0,-164000.0,,,,,,,,,,,23380000.0,,,,-373021000.0,1202000.0,,1400000.0,,,84728000.0,4932000.0,,7.19,,,,,0.0,6431.0,0.85,114708000.0,0.0,,,4932000.0,673182.0,2787000.0,,,5251892.0,,4600000.0,2677000.0,,200000.0,-100000.0,459000.0,0.0,21000000.0,9000.0,,,,,,52367444.0,,
2020-03-31,2020-05-12,10-Q,Osmotica Pharmaceuticals plc,RVLP,CIK0001739426,USD,8784000.0,32644000.0,3292000.0,,,47256000.0,3434000.0,,-2229000.0,521484000.0,616000.0,,,1000000.0,,333000.0,4400000.0,,475134000.0,189664000.0,,,,0.0,,,,,125830000.0,29965000.0,,,0.0,,0.01,400000000.0,58898708.0,58898708.0,589000.0,,,,0.0,,0.0,29200000.0,20590000.0,,,,,,,,,3200000.0,,,,,829000.0,2329000.0,,,,,,,,,,,,,,,,,,,,,,5562000.0,,,,,,-0.05,,,,,,,,,,,,,,,8900000.0,,,,110000.0,29000.0,,,33000.0,,,216608000.0,20203000.0,,13088000.0,10682000.0,11805000.0,12685000.0,17161000.0,85624000.0,3000.0,,,100855000.0,,,,28059000.0,,,,,,-2123000.0,,,,,,,,,,,,960000.0,474000.0,289000.0,-11242000.0,-769000.0,18000.0,-891000.0,,366232000.0,149624000.0,4064000.0,5375000.0,14085000.0,20536000.0,5323000.0,1128000.0,,,,,,,,,,331394000.0,475134000.0,58154000.0,,,,0.0,50000000.0,,268236000.0,,268236000.0,,,,,,,30975000.0,,-946000.0,,-64000.0,,-3083000.0,,,746000.0,1.0,1.0,,26864000.0,1195000.0,,2004000.0,2646000.0,,4471000.0,,,,,,,,,,533000.0,,,,,,,,,,167000.0,,,,616000.0,,949000.0,0.01,40000000.0,0.0,0.0,,10654000.0,,31791000.0,,,,,4000.0,-3083000.0,,,,,29987000.0,29000.0,,,,,,,,,,,5688000.0,,,,-376104000.0,48649000.0,,,,,21176000.0,1107000.0,0.0,,1165364.0,237163.0,,,,,0.85,143740000.0,,,31789000.0,1109000.0,29000.0,167000.0,,,,,,,,,,,,,,,,,,,58257191.0,,
2020-06-30,2020-08-11,10-Q,Osmotica Pharmaceuticals plc,RVLP,CIK0001739426,USD,8798000.0,17024000.0,6038000.0,,,48353000.0,3396000.0,,-2229000.0,521655000.0,133000.0,,,1200000.0,,,4400000.0,,462697000.0,186792000.0,,,,0.0,,,,,140376000.0,,,,0.0,,0.01,400000000.0,58760746.0,58760746.0,588000.0,,,,0.0,,0.0,25977000.0,261000.0,,,,,,,,,2800000.0,,,,,,2182000.0,,,,,,,,,,,,,,,,,,,,,,,5880000.0,1343000.0,,,-0.22,-0.22,-0.22,,,,,,,,,,,,,,15700000.0,,,,89000.0,17000.0,,,,,,220971000.0,19465000.0,16513000.0,8437000.0,,10034000.0,11157000.0,12037000.0,77643000.0,,,,100855000.0,,,,-27000.0,3618000.0,,,-17536000.0,,-18686000.0,,,-0.3,0.08,4537000.0,,-0.3,0.08,,,,-1150000.0,,,,,,,,366232000.0,141643000.0,1239000.0,,14578000.0,20301000.0,4596000.0,1127000.0,,,,,,,,,,331786000.0,462697000.0,58890000.0,,,,0.0,50000000.0,,268522000.0,,268522000.0,,,,,,,,,,,,,-12999000.0,,,-130000.0,,,,17290000.0,-17317000.0,,1650000.0,2175000.0,,3658000.0,,,,,,,,,,468000.0,,,,,,,,,,,,,,,,,0.01,40000000.0,0.0,0.0,,9091000.0,,,,,,,,-12999000.0,,29281000.0,,,,,,,,,,,,,,,2953000.0,,,,-389103000.0,234000.0,,,,,14337000.0,,1731926.0,,2831600.0,60185.0,,,,,,130911000.0,,,,1222000.0,169257.0,919000.0,,,,,,,,,,,,,,,,,,58863508.0,58863508.0,58863508.0,
2020-09-30,2020-11-10,10-Q,Osmotica Pharmaceuticals plc,RVLP,CIK0001739426,USD,7909000.0,21569000.0,7242000.0,,,45376000.0,2979000.0,,-2229000.0,550020000.0,,,,1300000.0,,,4200000.0,,427246000.0,176170000.0,,,,0.0,,,,,126093000.0,,,,0.0,,0.01,400000000.0,63105832.0,63105832.0,631000.0,,,,0.0,,,22602000.0,1185000.0,,,,,,,,,2100000.0,,13000.0,,,,526000.0,,,,,,,,,,,,,,,,,,,,,,,-10171000.0,177000.0,,,-0.14,-0.14,-0.14,,,,,,,,,,,,,,13900000.0,,,,65000.0,8000.0,,,,,,225171000.0,19501000.0,12177000.0,3120000.0,,4774000.0,6723000.0,7609000.0,53904000.0,,,,100855000.0,,,,24566000.0,19539000.0,,,1715000.0,,407000.0,,,0.03,0.03,-10348000.0,,-0.16,-0.16,,200000.0,,-1308000.0,,,,,,,,366232000.0,117904000.0,1071000.0,,16526000.0,21703000.0,4574000.0,603000.0,,,,,,,,,,276560000.0,427246000.0,54946000.0,,,,0.0,50000000.0,,219290000.0,,219290000.0,,,,,,,,,,,,,-8633000.0,,,51000.0,,,,23139000.0,1427000.0,,1596000.0,1790000.0,,3233000.0,,,,,,,,,,420000.0,,,,,,,,,,,,,,,,,0.01,40000000.0,0.0,0.0,,6805000.0,,,,,,,,-8633000.0,,28664000.0,,,,,,,,,,,,,,,1779000.0,,,,-397736000.0,25751000.0,,,,,21360000.0,,35500.0,,2785197.0,0.0,,,,,,150686000.0,,,30649000.0,1508000.0,677468.0,3749000.0,,,,1300000.0,,,,,,,,,,,,,,63285258.0,62785866.0,62785866.0,
2020-12-31,2021-03-30,10-K,Osmotica Pharmaceuticals plc,RVLP,CIK0001739426,USD,3128000.0,3149000.0,6232000.0,2000.0,,16951000.0,29000.0,,-2229000.0,548070000.0,749000.0,,6800000.0,3900000.0,,1269000.0,0.0,,370949000.0,173154000.0,41529000.0,,,0.0,,,,,114053000.0,18188000.0,,,0.0,0.0,0.01,400000000.0,62545832.0,62545832.0,625000.0,-79589000.0,100000.0,26000.0,0.0,,,88000.0,3293000.0,,-4145000.0,80000.0,-3833000.0,232000.0,221400000.0,,-1660000.0,1800000.0,-99000.0,28000.0,,-1949000.0,-1156000.0,345000.0,-190000.0,19082000.0,295000.0,2393000.0,1285000.0,3327000.0,6486000.0,1816000.0,5921000.0,,27811000.0,345000.0,,9254000.0,,623000.0,658000.0,3261000.0,500000.0,0.03,1900000.0,21026000.0,10508000.0,1084000.0,102141000.0,,,-1.31,,0.0613,0.21,-0.1387,0.0346,-0.0328,-0.006,-0.005,0.0115,0.012,-0.0326,,,,800000.0,113860.0,1000.0,,20000.0,4000.0,,,127000.0,22000.0,0.0167,228291000.0,7321000.0,10193000.0,,,2790000.0,4739000.0,5625000.0,30668000.0,-287000.0,,,55847000.0,28900000.0,86300000.0,0.0,24469000.0,28910000.0,,,-89013000.0,-75325000.0,-94795000.0,-19470000.0,-1.47,,,9424000.0,0.16,,,1900000.0,,500000.0,-5782000.0,2044000.0,-1723000.0,-17496000.0,-3371000.0,,3209000.0,,64000000.0,35090000.0,4095000.0,14745000.0,1593000.0,1831000.0,148000.0,90000.0,1657000.0,2196000.0,1288000.0,,,261000.0,647000.0,,126000.0,277093000.0,370949000.0,55784000.0,34484000.0,568000.0,,,,,219525000.0,,219525000.0,,,,,,,3682000.0,,-3084000.0,,17590000.0,,-79600000.0,,,-48000.0,1.0,1.0,1.0,115121000.0,-90652000.0,2070000.0,1199000.0,871000.0,1630000.0,1953000.0,,,,,,,,,0.0537,373000.0,,,,,,,,,,8101000.0,,,,749000.0,0.0,2920000.0,0.01,40000000.0,0.0,0.0,0.0,12592000.0,,62440000.0,,,,,50000.0,-79589000.0,2131000.0,2391000.0,600000.0,,,6000.0,,,,,,,50000000.0,,,,13387000.0,,,,-452610000.0,27762000.0,0.0,200000.0,,,72824000.0,4925000.0,,,,,,,0.0,8832.0,0.85,93856000.0,51905.0,,62440000.0,5147000.0,1435725.0,8101000.0,,,,1400000.0,6700000.0,171000.0,2677000.0,200000.0,,171000.0,0.0,6600000.0,5000.0,70000.0,74000.0,,,,60652999.0,,496000.0
2021-03-31,2021-05-13,10-Q,Osmotica Pharmaceuticals plc,RVLP,CIK0001739426,USD,4522000.0,22592000.0,5032000.0,6000.0,1000.0,42720000.0,2276000.0,,-2229000.0,549021000.0,358000.0,,,1200000.0,,277000.0,2634000.0,,355168000.0,161354000.0,,,,0.0,,,,,109212000.0,-4841000.0,,,0.0,,0.01,400000000.0,62719131.0,62719131.0,627000.0,,,,0.0,,,19703000.0,13490000.0,,,,,,,,,1600000.0,,,,,83000.0,427000.0,,,,,,,,,,,,,,,,,,,,,,3986000.0,,,,,,-0.15,,,,,,,,,,,,,,11100000.0,,,,,27000.0,2000.0,,,16000.0,,,230925000.0,6246000.0,5625000.0,7560000.0,,1074000.0,2790000.0,4739000.0,28034000.0,3000.0,5636000.0,,100855000.0,,86300000.0,0.0,10390000.0,,,,,,-9079000.0,,,,,,,,,,,,533000.0,258000.0,-2246000.0,-3817000.0,-655000.0,,-1398000.0,,294049000.0,63124000.0,2960000.0,2706000.0,12787000.0,16950000.0,2870000.0,1293000.0,,,,,,,,,,269971000.0,355168000.0,48650000.0,,,,0.0,50000000.0,,219755000.0,,219755000.0,,,,,,,-236000.0,,6881000.0,,-11486000.0,,-9612000.0,,,87000.0,1.0,1.0,,22232000.0,-6206000.0,,1375000.0,1136000.0,,2386000.0,,,,,,,,,,326000.0,,,,,,,,,,,,,,358000.0,,422000.0,0.01,40000000.0,0.0,0.0,,12600000.0,,,,,7300000.0,,3000.0,-9612000.0,,27123000.0,,,,5000.0,,,,,,,,,,,3310000.0,,,,-462222000.0,23880000.0,,,,,18922000.0,1177000.0,69000.0,,2545483.0,214231.0,,,,,0.85,85197000.0,,,,1311000.0,0.0,,,,,,,,,,,,,,,,,,,,62678130.0,,
2021-06-30,2021-08-16,10-Q,Osmotica Pharmaceuticals plc,RVLP,CIK0001739426,USD,1549000.0,645000.0,6032000.0,138000.0,1000.0,13420000.0,96000.0,,-2229000.0,550004000.0,249000.0,,,,,,,,335011000.0,249483000.0,134133000.0,,,0.0,,,,,99777000.0,,,,0.0,,0.01,400000000.0,62848062.0,62848062.0,628000.0,,,,0.0,,,,709000.0,,,,,,216100000.0,,,1300000.0,,,,,,611000.0,,,,,,,,,,,,,,,,,,,,,,,4454000.0,213000.0,,,-0.28,,-0.28,,,,,,,,,,,,,9000000.0,,,,,7000.0,,,,,,,,,,,,,,,,,,,55847000.0,,,,10801000.0,7880000.0,,,-21968000.0,,-21874000.0,,,-0.35,0.07,4241000.0,,-0.35,0.07,,,,94000.0,,,,,,,,35090000.0,27210000.0,494000.0,,1020000.0,1020000.0,,,,,,,,,,,,266557000.0,335011000.0,265511000.0,34674000.0,,,0.0,25000000.0,,214720000.0,214720000.0,,,,,,,,,,,,,,-17727000.0,,,-1202000.0,,,,30979000.0,-20178000.0,,1003000.0,434000.0,,1344000.0,,,,,,,,,,279000.0,,,,,,,,,,,,,,,,,0.01,40000000.0,0.0,0.0,,13908000.0,,,,,,,,-17727000.0,,848000.0,,,,,,,,,,,,,,,2052000.0,,4500000.0,,-479949000.0,11510000.0,,,,,21047000.0,,,,2149329.0,,,,,,,68454000.0,,,,1233000.0,,,,,,,,,,,,,,,1375000.0,,,,,62767400.0,,62767400.0,
2021-09-30,2021-11-15,10-Q,Osmotica Pharmaceuticals plc,RVLP,CIK0001739426,USD,4449000.0,4190000.0,6570000.0,,1000.0,18521000.0,144000.0,,-2229000.0,554156000.0,160000.0,,,,,,,,109547000.0,23385000.0,,,,0.0,,,,,8352000.0,,,,0.0,0.0,0.01,400000000.0,63127288.0,63127288.0,631000.0,,,,0.0,,200000.0,,1147000.0,,,,,,,,,100000.0,,206000.0,,,,165000.0,,,,,,,,,,,,,,,,,,,,,,,3983000.0,-132000.0,,,-0.28,,-0.28,,,,,,,,,,,,,5400000.0,,,,,6000.0,,,,,,,,,,,,,,,,,,4373000.0,55847000.0,,,,1049000.0,,,,-26347000.0,,-26023000.0,,,-0.42,-0.42,8488000.0,,0.13,0.13,,,,324000.0,,,,,,,,35090000.0,27210000.0,735000.0,,824000.0,824000.0,,,,,,,,,,,,54797000.0,109547000.0,53930000.0,,,,,,,29925000.0,29925000.0,,,,,,,,,,,,,,-17859000.0,,,-120000.0,,,,26217000.0,-25168000.0,,1029000.0,701000.0,,1651000.0,,,,,,,,,,603000.0,,,,,,,,,,,,,,,,,0.01,40000000.0,0.0,0.0,0.0,10019000.0,,,,,,,,-17859000.0,,851000.0,,,,,,,,,,,,,,,1376000.0,,,,-497808000.0,2196000.0,,,,,24841000.0,,,,1456910.0,,,,,,,54750000.0,,,36000.0,4279000.0,,,,,,,,,,,,,,,,,,,,62945898.0,,62945898.0,1400000.0
